Sihuan Pharmaceutical Holdings Group Ltd (0460.HK)
Company Info
BMG8162K1137
Mar 23, 2007
Highlights
HK$6.86B
HK$0.48 - HK$1.02
HK$2.74
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Sihuan Pharmaceutical Holdings Group Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Sihuan Pharmaceutical Holdings Group Ltd (0460.HK) returned 9.09% year-to-date (YTD) and 22.55% over the past 12 months. Over the past 10 years, 0460.HK returned -15.08% annually, underperforming the S&P 500 benchmark at 10.31%.
0460.HK
9.09%
28.57%
0.00%
22.55%
0.92%
-15.08%
^GSPC (Benchmark)
-4.26%
11.24%
-5.02%
8.55%
14.02%
10.31%
Monthly Returns
The table below presents the monthly returns of 0460.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -10.61% | -0.00% | -3.39% | 26.32% | 0.00% | 9.09% | |||||||
| 2024 | -16.93% | 5.56% | -7.01% | 7.54% | -5.26% | -3.71% | 1.94% | 1.88% | 24.98% | 12.31% | -5.48% | -4.35% | 5.41% |
| 2023 | 5.25% | -9.00% | -13.18% | 1.26% | -7.49% | 10.88% | -2.57% | -15.79% | -4.69% | 8.20% | 4.55% | -5.79% | -28.03% |
| 2022 | -2.03% | 15.17% | -5.99% | -19.74% | -9.14% | 13.27% | -12.50% | -10.71% | -23.90% | -11.84% | 28.36% | 10.46% | -34.89% |
| 2021 | 135.37% | 23.83% | -14.64% | 51.96% | 22.58% | -12.63% | -20.07% | -12.50% | -28.14% | -1.21% | -7.32% | -2.63% | 81.42% |
| 2020 | -4.30% | 3.37% | -15.22% | -0.00% | -2.57% | -1.07% | 6.77% | 18.98% | -11.59% | 7.23% | -0.00% | -7.87% | -10.30% |
| 2019 | 20.44% | -0.60% | 15.86% | 11.05% | -16.59% | 0.86% | -7.95% | -13.58% | -15.00% | -13.09% | -13.59% | 4.49% | -31.26% |
| 2018 | 6.76% | -4.67% | -18.88% | -17.67% | 6.28% | -13.13% | -3.43% | 2.96% | -8.05% | -0.29% | 9.44% | -21.27% | -50.71% |
| 2017 | 6.02% | 15.72% | 11.32% | 17.29% | -3.18% | -1.19% | 0.61% | -8.51% | -4.99% | -0.70% | -2.48% | 2.18% | 32.63% |
| 2016 | 0.00% | -54.87% | 11.56% | -19.37% | -6.70% | -8.90% | 19.05% | 0.00% | -1.99% | 9.42% | 12.90% | 2.85% | -48.86% |
| 2015 | -3.47% | -7.79% | -4.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.39% | 0.00% | 0.00% | 0.36% | -14.39% |
| 2014 | 16.95% | 13.41% | -0.42% | -8.66% | 8.20% | 3.18% | 1.06% | 8.35% | 12.47% | 6.36% | -6.30% | -10.52% | 47.88% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 76, 0460.HK is among the top 24% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Sihuan Pharmaceutical Holdings Group Ltd (0460.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Sihuan Pharmaceutical Holdings Group Ltd provided a 2.92% dividend yield over the last twelve months, with an annual payout of HK$0.02 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | HK$0.02 | HK$0.02 | HK$0.04 | HK$0.02 | HK$0.02 | HK$0.02 | HK$0.02 | HK$0.02 | HK$0.06 | HK$0.07 | HK$0.03 | HK$0.04 |
Dividend yield | 2.92% | 3.18% | 5.69% | 1.79% | 1.08% | 1.84% | 2.10% | 1.53% | 2.24% | 3.19% | 0.75% | 0.83% |
Monthly Dividends
The table displays the monthly dividend distributions for Sihuan Pharmaceutical Holdings Group Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 |
| 2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 |
| 2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.02 |
| 2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 |
| 2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.07 |
| 2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.03 |
| 2014 | HK$0.03 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Sihuan Pharmaceutical Holdings Group Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Sihuan Pharmaceutical Holdings Group Ltd was 90.70%, occurring on Feb 5, 2024. The portfolio has not yet recovered.
The current Sihuan Pharmaceutical Holdings Group Ltd drawdown is 86.09%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.7% | Oct 17, 2014 | 2291 | Feb 5, 2024 | — | — | — |
| -58.41% | Nov 30, 2010 | 180 | Aug 22, 2011 | 498 | Aug 30, 2013 | 678 |
| -17.22% | Sep 10, 2013 | 3 | Sep 12, 2013 | 17 | Oct 9, 2013 | 20 |
| -17.06% | Mar 21, 2014 | 30 | May 7, 2014 | 42 | Jul 8, 2014 | 72 |
| -9.68% | Jul 18, 2014 | 11 | Aug 1, 2014 | 15 | Aug 22, 2014 | 26 |
Volatility
Volatility Chart
The current Sihuan Pharmaceutical Holdings Group Ltd volatility is 21.86%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Sihuan Pharmaceutical Holdings Group Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Sihuan Pharmaceutical Holdings Group Ltd, comparing actual results with analytics estimates. The company met analyst expectations for EPS in the past quarter.
Valuation
The Valuation section provides an overview of how Sihuan Pharmaceutical Holdings Group Ltd is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 0460.HK compared to other companies in the Drug Manufacturers - Specialty & Generic industry. 0460.HK currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 0460.HK relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0460.HK has a P/S ratio of 3.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 0460.HK in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0460.HK has a P/B value of 1.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |